Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Regional Health Properties Inc (RHE$A)

  • SEC News
  • Jan. 06, 2026, 21:11 UTC
  • 2
  • 1 comments

(99% Neutral) Regional Health Properties, Inc. (RHE$A) Announces Regulatory Update

Comment Full text

Celsion Corporation (the company was transformed to Imunon (IMNN)) (CLSN)

  • SEC News
  • Jan. 06, 2026, 21:11 UTC
  • 2
  • 1 comments

Bragg Kimberly 🟢 acquired 9.1K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000615

Comment Full text

Mersana Therapeutics (MRSN)

  • SEC News
  • Jan. 06, 2026, 21:11 UTC
  • 2
  • 0 comments

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001303 Size: 30 KB

Comment Full text

Sight Sciences Inc (SGHT)

  • SEC News
  • Jan. 06, 2026, 21:11 UTC
  • 2
  • 1 comments

📋 Badawi Paul (Officer) plans to sell 12K shares of Sight Sciences, Inc. (at $7.48 each, total $89K) Filed: Jan 06, 2026 | ID: 000149

Comment Full text

OPKO Health Inc. (OPK)

  • Business News
  • Jan. 06, 2026, 21:11 UTC
  • 4
  • 1 comments

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Century Therapeutics Inc (IPSC)

  • SEC News
  • Jan. 06, 2026, 21:10 UTC
  • 2
  • 1 comments

Cowan Chad 🔴 sold 1.6K shares of Century Therapeutics, Inc. (IPSC) at $0.99 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

Evolent Health Inc (EVH)

  • SEC News
  • Jan. 06, 2026, 21:10 UTC
  • 2
  • 1 comments

Director Smith Jill D. 🟢 acquired 23.1K shares of Evolent Health, Inc. (EVH) Transaction Date: Jan 02, 2026 | Filing ID: 000006

Comment Full text

EyePoint Pharmaceuticals Inc (EYPT)

  • SEC News
  • Jan. 06, 2026, 21:10 UTC
  • 2
  • 1 comments

Duker Jay S. 🟡 adjusted position in 458.0K shares (4 derivative) of EyePoint, Inc. (EYPT) at $17.48 ($6.4M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

Mersana Therapeutics (MRSN)

  • SEC News
  • Jan. 06, 2026, 21:10 UTC
  • 2
  • 0 comments

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001300 Size: 30 KB

Comment Full text

Regeneron Pharmaceuticals Inc (REGN)

  • SEC News
  • Jan. 06, 2026, 21:10 UTC
  • 2
  • 1 comments

Director BROWN MICHAEL S 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

Tango Therapeutics Inc. (TNGX)

  • SEC News
  • Jan. 06, 2026, 21:10 UTC
  • 2
  • 1 comments

Lee Sung 🟢 acquired 70.0K shares (1 derivative) of Tango Therapeutics, Inc. (TNGX) at $8.93 Transaction Date: Jan 02, 2026 | Filing ID: 004433

Comment Full text

Barinthus Biotherapeutics Inc. (BRNS)

  • SEC News
  • Jan. 06, 2026, 21:09 UTC
  • 2
  • 1 comments

(99% Neutral) BARINTHUS BIOTHERAPEUTICS PLC (BRNS) Files Form 8-K

Comment Full text

EyePoint Pharmaceuticals Inc (EYPT)

  • SEC News
  • Jan. 06, 2026, 21:09 UTC
  • 2
  • 1 comments

Zaderej Karen L. 🟢 acquired 40.0K shares (1 derivative) of EyePoint, Inc. (EYPT) at $17.48 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Comment Full text

Celsion Corporation (the company was transformed to Imunon (IMNN)) (CLSN)

  • SEC News
  • Jan. 06, 2026, 21:09 UTC
  • 2
  • 1 comments

Anwer Khursheed 🟢 acquired 15.7K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000613

Comment Full text

Mersana Therapeutics (MRSN)

  • SEC News
  • Jan. 06, 2026, 21:08 UTC
  • 2
  • 0 comments

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001298 Size: 30 KB

Comment Full text
  • Previous
  • 586
  • 587
  • 588
  • 589
  • 590
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191988)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125314)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin